openPR Logo
Press release

Bronchiectasis Market To Discern Magnified Growth During 2025

02-02-2018 03:20 PM CET | Health & Medicine

Press release from: Transparency Market Research

Bronchiectasis Market To Discern Magnified Growth During 2025

Bronchiectasis is a chronic and life-threatening disease, wherein parts of airways of lungs are permanently enlarged. This condition damages the bronchial tubes of lungs permanently and also widens, and thickens them. Inflammation and infection in the bronchi leads to this condition. The severity of bronchiectasis symptoms may vary widely. The most common symptom of bronchiectasis is breathlessness i.e., difficulty in breathing or feeling short of breath, frequent chest infections, and coughing that regularly brings up phlegm (sputum). Bronchiectasis is also called non-cystic fibrosis bronchiectasis due to the similar symptoms among people who have cystic fibrosis.

View Report -
https://www.transparencymarketresearch.com/bronchiectasis-market.html

Bronchiectasis is a condition in which the airways are inflamed and scarred with thick mucus, also known as sputum or phlegm. The airways become broadened and unable to clear themselves appropriately. This condition leads to building of mucus in between airways and which have high chances to acquiring bacterial infection. Therefore, it is essential to diagnose and treat chest infection. Having severe lung infection such as pneumonia, tuberculosis in the past, inflammatory bowel disease, immune system deficiencies, and other such illness are linked to bronchiectasis. Bronchiectasis can also develop in patients suffering from asthma and COPD.

It is a form of COPD which also consists of chronic bronchitis and emphysema. Bronchiectasis may also be congenital or acquired. Congenital bronchiectasis can be caused due to cystic fibrosis, Kartagener syndrome, Young's syndrome, and Alpha-1-antitrypsin deficiency. Acquired bronchiectasis is caused due to recurrent infection, alcohol, and drug abuse, tuberculosis, inflammatory bowel disease, etc.

Due to various symptoms, patients may have to undergo several tests such as chest X-ray, sputum test, blood test, and computerized tomography (CT) scan which allows a more detailed look into lungs, and lung function test. Many health care professionals also suggest bronchoscopy, which helps to look inside the airways through a narrow tube with camera inserted via mouth or nose into the lungs. During bronchoscopy, a small piece of tissue or cells can be removed for testing. This is known as biopsy.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26945

The bronchiectasis market has been segmented based on drug type, distribution channel, and region. In terms of drug type, the bronchiectasis market has been segmented into antibiotics, inhaled steroids, bronchodilator, combination drug (bronchodilator + inhaled corticosteroid), and others. Other treatments for bronchiectasis include vaccinations, embolization, and physiotherapy. Most common physiotherapies practiced for bronchiectasis are clearing sputum from lungs, and techniques and exercises to overcome breathlessness, which is one of the major symptoms of bronchiectasis.

Based on distribution channel, the bronchiectasis market has been segmented into hospital pharmacies, retail pharmacies, drug stores, and e-commerce. Hospital pharmacies emerged as the leading segment, attributed to the large demand as all the medical diagnostics and treatments for respiratory diseases are carried out in hospitals and most of the drugs prescribed by doctors are sold in hospital pharmacies. Retail pharmacies is the second largest segment, followed by drug stores and e-commerce.

In terms of region, the global bronchiectasis market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the market due to high health awareness and technological advancement in the region. Europe held the second largest share of the bronchiectasis market due to rising research and development. However, Asia Pacific and Latin America are expected to offer significant opportunities in the bronchiectasis market due to increasing prevalence of respiratory diseases in the low and middle-income countries in these regions. Increasing population, high demand for low cost drugs, and growing awareness about respiratory diseases are likely to drive the bronchiectasis market in Asia Pacific, Latin America, and MEA.

Key players in the bronchiectasis market are Bayer AG, GlaxoSmithKline plc, Merck & Co., Inc., AstraZeneca, and Teva Pharmaceutical Industries Ltd., among others.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=26945<ype=S

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiectasis Market To Discern Magnified Growth During 2025 here

News-ID: 929329 • Views:

More Releases from Transparency Market Research

Non-Destructive Testing Market Projected to Reach $31.9 Billion by 2034: TMR Analysis
Non-Destructive Testing Market Projected to Reach $31.9 Billion by 2034: TMR Ana …
The Global Non-Destructive Testing (NDT) Market (비파괴 검사(NDT) 시장) is set to witness significant growth, projected to reach an estimated value of $31.9 billion by the end of 2034. This growth trajectory follows a valuation of $15.5 billion in 2023, fueled by a compound annual growth rate (CAGR) of 6.7% from 2024 to 2034. The increase in demand for inspection and health monitoring of concrete and steel structures is a primary
Outdoor Power Equipment Market Set to Reach $42.8 Billion by 2034, Driven by Sustainable Solutions and Growing Landscaping Demand
Outdoor Power Equipment Market Set to Reach $42.8 Billion by 2034, Driven by Sus …
The Global Outdoor Power Equipment Market (屋外用電動機器市場), valued at $30.5 billion in 2023, is projected to experience robust growth over the next decade. According to recent industry analysis, the market is expected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching an estimated $42.8 billion by 2034. This growth is largely attributed to the increasing adoption of landscaping services and a rising demand for sustainable solutions in
Global Semiconductor IP Market to Reach $13.5 Billion by 2034, Growing at a 5.9% CAGR: TMR Analysis
Global Semiconductor IP Market to Reach $13.5 Billion by 2034, Growing at a 5.9% …
The Global Semiconductor Intellectual Property (IP) Market (반도체 지적재산권(IP) 시장), valued at US$ 7.1 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2034, reaching US$ 13.5 billion by the end of the forecast period. This growth is primarily fueled by increasing demand for AI-based applications across various industries and government initiatives aimed at modernizing defense technologies. Download Sample PDF from
Glass Wafer Carrier Market to Surge, Expected to Reach $2.2 Billion by 2031: TMR Analysis
Glass Wafer Carrier Market to Surge, Expected to Reach $2.2 Billion by 2031: TMR …
The Global Glass Wafer Carrier Market (ガラスウェーハキャリア市場) is poised for significant growth, expected to reach a valuation of US$ 2.2 billion by 2031, advancing at a remarkable CAGR of 19.2% from 2024. The surge in demand for semiconductors in automotive and IT & telecommunications sectors is driving this trend, positioning glass wafer carriers as critical components in semiconductor manufacturing processes. Analysts indicate that the automotive industry's increased focus on vehicle safety,

All 5 Releases


More Releases for Bronchiectasis

Bronchiectasis Global Market Research Report 2025
Bronchiectasis Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/bronchiectasis-market/80987 The report firstly introduced the Bronchiectasis basics: definitions, classifications, applications and market overview; product
Bronchiectasis - Market Insights, Epidemiology and Market Forecast 2018-2027
Bronchiectasis Market: WiseGuyReports.com adds “Bronchiectasis Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2027” reports tits database. Executive Summary “Bronchiectasis - Market Insights, Epidemiology and Market Forecast – 2027” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market
Bronchiectasis Therapeutics Analysis - Clinical Trials & Results, Collaboration …
The study analysed that the Bronchiectasis therapeutics pipeline comprises approximately 13 drug candidates in different stages of development. Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways
Bronchiectasis Treatment Market Foraying into Emerging Economies 2017 - 2025
Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in serious health conditions such as heart failure and respiratory failure. Mucus producing cough is the major symptom of this condition. Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/21037
Bronchiectasis Therapeutics Clinical Trials, Pipeline Analysis & Collaboration
Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot
Bronchiectasis Market: Upcoming Demands and Growth Analysis 2025
Bronchiectasis is a chronic and life-threatening disease, wherein parts of airways of lungs are permanently enlarged. This condition damages the bronchial tubes of lungs permanently and also widens, and thickens them. Inflammation and infection in the bronchi leads to this condition. The severity of bronchiectasis symptoms may vary widely. The most common symptom of bronchiectasis is breathlessness i.e., difficulty in breathing or feeling short of breath, frequent chest infections, and